Multiple Hospitals Adopt Omnicell's XR2 Automated Central Pharmacy System to Enhance Medication Inventory Management

Cloud-Computing überträgt Daten zwischen Geräten. (Symbolbild). © PeopleImages / E+

PR Newswire

MOUNTAIN VIEW, Calif., Feb. 6, 2018

MOUNTAIN VIEW, Calif., Feb. 6, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that several U.S. hospitals have adopted the Company's newest robotic solution to automate critical workflows in the central pharmacy. First introduced at the American Society of Health-System Pharmacists (ASHP) 2017 Midyear Meeting in December, the Omnicell^® XR2 Automated Central Pharmacy System utilizes robotic technology to eliminate numerous manual tasks, allowing pharmacy to redirect resources to clinical contributions that have meaningful impacts on patient outcomes. XR2 is part of Omnicell's industry-leading medication management automation platform.

Omnicell, Inc. logo. (PRNewsFoto/Omnicell, Inc.)

According to the American Pharmacist Association (APhA), positive interaction with hospital pharmacists can significantly impact patient satisfaction survey scores.¹ Pharmacists can play a key role in positively affecting patient outcomes with various clinical programs such as medication reconciliation, discharge management, and opioid stewardship.

Designed to meet the unique and evolving needs of pharmacy operations, XR2 is a key technological step toward the fully automated pharmacy. The system automates critical workflows in the central pharmacy with high capacity and formulary coverage, and significant efficiency improvements such as dispensing earliest expiring medications first and reducing the need for repackaging. With 100% barcode scanning, XR2 helps minimize human error and discrepancies, enabling more accurate management of inventory levels.

"Automation offers many benefits, including increased safety, efficiency, and cost savings," said Patrick Ferguson, RPh, MBA, network director of pharmacy services at St. Luke's University Health Network. "Automation also shifts the focus of our pharmacy staff from logistical tasks to a more active role in patient care, improving job satisfaction and supporting our commitment to patient-centered care."

Other early adopters of this innovative technology include:

Mercyhealth in Rockford, Illinois
Sentara Healthcare in Charlottesville, Virginia
Summa Health in Akron, Ohio
UPMC in Pittsburgh, Pennsylvania

"At Omnicell, we're dedicated to delivering solutions that will help our customers achieve the highest levels of success," said Nhat H. Ngo, executive vice president, Marketing, Strategy and Business Development at Omnicell. "These leaders in pharmacy automation adoption are empowering their teams to perform at the top of their licenses, which directly impacts safety and satisfaction for both providers and patients."

ARIVA.DE Börsen-Geflüster

Kurse

Omnicell

25,20 €

-1,56%

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. Omnicell is revolutionizing the patient medication experience from hospital to home by empowering providers to keep each patient at the center of care. The Company's autonomous approach to medication management leverages a differentiated platform for hardware and workflow software solutions, real-time predictive intelligence, and performance-driven partnerships to help drive operational, financial, and clinical success for customers.

Supporting the highest level of patient safety is essential to excellent patient care. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on delivering solutions for medication availability, affordability, safety, and adherence. Over 4,000 customers worldwide use Omnicell^® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety.

Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

For more information about Omnicell, Inc. please visit www.omnicell.com.

OMCL-G

Editor's Notes:

All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, omnicell.com.
Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
All other brand or product names may be trademarks or registered trademarks of their respective companies.

¹ Erickson, A. K. (2013, October 11). "Survey says: Pharmacists affect patient satisfaction." Retrieved January 08, 2018 from https://www.pharmacist.com/survey-says-pharmacists-affect-patient-satisfaction

View original content with multimedia:http://www.prnewswire.com/news-releases/multiple-hospitals-adopt-omnicells-xr2-automated-central-pharmacy-system-to-enhance-medication-inventory-management-300594552.html

SOURCE Omnicell, Inc.

Mehr Nachrichten zur Omnicell Aktie kostenlos abonnieren

E-Mail-Adresse

Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.